This company has shut down. Versantis is no longer operating — its last tracked round was a Grant in 2022.
Explore the Startup GraveyardVersantis is a pharmaceutical company developing medicine to revolutionize the care of patients.
Versantis has raised $509K in total funding. The most recent round was Grant. The last funding was announced in April 2022.
Versantis's investors include Verve Ventures, redalpine, Zürcher Kantonal Bank, Venture Kick, MassChallenge.
Versantis is headquartered in Zürich, Switzerland.
Versantis is a pharmaceutical company developing medicine to revolutionize the care of patients.
Versantis is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Versantis — Funding & Investors." VCBacked, April 13, 2022, https://www.vcbacked.co/company/versantis. Accessed August 15, 2026.
VCBacked. (2022). Versantis — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/versantis
{{cite web |title=Versantis — Funding & Investors |url=https://www.vcbacked.co/company/versantis |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated